Immix Biopharma (IMMX) Accounts Payables (2020 - 2026)

Quarterly results put Accounts Payables at $193715.0 for Q1 2026, up 52.09% from a year ago — trailing twelve months through Mar 2026 was $193715.0 (up 52.09% YoY), and the annual figure for FY2025 was $5.4 million, up 4100.71%.

Immix Biopharma has reported Accounts Payables over the past 7 years, most recently at $193715.0 for Q1 2026.

  • Accounts Payables reached $193715.0 in Q1 2026 per IMMX's latest filing, down from $5.4 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $6.6 million in Q2 2025 and bottomed at $122594.0 in Q1 2024.
  • Median Accounts Payables over the past 5 years was $1.3 million (2022), compared with a mean of $2.2 million.
  • Peak annual rise in Accounts Payables hit 4100.71% in 2025, while the deepest fall reached 97.37% in 2025.
  • Over 5 years, Accounts Payables stood at $1.3 million in 2022, then soared by 192.3% to $3.7 million in 2023, then plummeted by 96.52% to $129567.0 in 2024, then skyrocketed by 4100.71% to $5.4 million in 2025, then crashed by 96.44% to $193715.0 in 2026.
  • Business Quant data shows Accounts Payables for IMMX at $193715.0 in Q1 2026, $5.4 million in Q4 2025, and $170896.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1.05 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 10.62 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 8.64 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 489.30 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 1.03 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 126.63 Mn
10 Immix Biopharma 476.17 Mn 476.17 Mn - 193,715.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 193,715.00
Dec 31, 2025 5.44 Mn
Sep 30, 2025 170,896.00
Jun 30, 2025 6.61 Mn
Mar 31, 2025 127,367.00
Dec 31, 2024 129,567.00
Sep 30, 2024 6.50 Mn
Jun 30, 2024 3.85 Mn
Mar 31, 2024 122,594.00
Dec 31, 2023 3.72 Mn
Sep 30, 2023 2.83 Mn
Jun 30, 2023 2.40 Mn
Mar 31, 2023 1.47 Mn
Dec 31, 2022 1.27 Mn
Sep 30, 2022 646,457.00
Jun 30, 2022 977,209.00
Mar 31, 2022 305,679.00
Dec 31, 2021 142,940.00
Dec 31, 2020 252,344.00